Cutler Group’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$0 Sell
57
-633
-92% -$4.19K ﹤0.01% 2727
2023
Q4
$4K Buy
+690
New +$3.88K ﹤0.01% 2827
2023
Q3
Sell
-4,138
Closed -$27.6K 3968
2023
Q2
$22K Sell
4,138
-2,772
-40% -$14.9K ﹤0.01% 1797
2023
Q1
$43K Buy
6,910
+4,756
+221% +$26.5K ﹤0.01% 1444
2022
Q4
$10K Sell
2,154
-3,763
-64% -$18.5K ﹤0.01% 2691
2022
Q3
$27K Buy
5,917
+3,189
+117% +$20.1K ﹤0.01% 2375
2022
Q2
$16K Buy
2,728
+1,528
+127% +$17K ﹤0.01% 2851
2022
Q1
$23K Sell
1,200
-3,468
-74% -$79.5K ﹤0.01% 2928
2021
Q4
$152K Sell
4,668
-720
-13% -$29K 0.01% 1542
2021
Q3
$221K Sell
5,388
-9,806
-65% -$356K 0.01% 1291
2021
Q2
$547K Sell
15,194
-23,251
-60% -$858K 0.03% 719
2021
Q1
$1.5M Buy
38,445
+4,460
+13% +$201K 0.07% 299
2020
Q4
$1.37M Buy
33,985
+19,600
+136% +$900K 0.07% 303
2020
Q3
$799K Buy
+14,385
New +$762K 0.05% 384

Other funds holding GDRX

Cutler Group's GDRX Position: Q1 2024 in Review

Cutler Group reduced its GoodRx Holdings (GDRX) stake by 92% in Q1 2024, selling an estimated $4.19K and leaving 57 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Cutler Group first reported a position in GDRX in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.5M in Q1 2021. 159 funds tracked by Wall St. Rank hold GDRX as of Q1 2024.

  • Cutler Group held 57 shares of GoodRx Holdings worth $0 as of Q1 2024.
  • Cutler Group sold 633 GoodRx Holdings shares in Q1 2024, an estimated $4.19K.
  • GoodRx Holdings made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #2727 holding.
  • Cutler Group first reported a position in GoodRx Holdings in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's GoodRx Holdings position peaked at $1.5M in Q1 2021.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.